BABA
Alibaba Group Holding Limited
BABA has the edge over CPHC overall, supported by stronger valuation and stronger modeled upside.
CPHC
Canterbury Park Holding Corporation
CPHC has lower modeled downside risk, despite its lower overall score.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
CPHC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
CPHC's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA has the edge over CPHC in the historical PE scenario, which offers more potential upside but is not a forecast.
CPHC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.8x | $0.98 | -94% |
| Fair | 17x | $1.66 | -89% |
| Expensive | 60x | $5.98 | -62% |
| Current | 157x | $15.70 | — |
Historical ranges are pointers, not guarantees.
CPHC's PE is in its expensive range at 157x.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
CPHC Forward outlook
There aren't enough analyst estimates for CPHC to show an outlook.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over CPHC on earnings, with more consistent year-over-year improvement.
CPHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.10 | +$0.37 |
| Q2 2026 | $0.02 | -33% |
| Q1 2026 | -$0.01 | -106% |
| Q4 2025 | -$0.10 | -124% |
| Q3 2025 | -$0.27 | -129% |
| Q2 2025 | $0.03 | -96% |
| Q1 2025 | $0.16 | -91% |
| Q4 2024 | $0.42 | -80% |
CPHC has returned to profit: it earned $0.10 per share over the past year, after losing money the year before.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over CPHC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
CPHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.1M | +4.2% |
| Q2 2026 | $16.2M | +3.2% |
| Q1 2026 | $13.5M | +2.8% |
| Q4 2025 | $12.4M | +3.9% |
| Q3 2025 | $18.3M | -5% |
| Q2 2025 | $15.7M | -3.3% |
| Q1 2025 | $13.1M | -6.8% |
| Q4 2024 | $12M | -4.4% |
CPHC's revenue grew through 2023 and has held roughly level since: $19M last quarter, up 4.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.9% | +3.2 points |
| Q2 2026 | 1.8% | -1 points |
| Q1 2026 | 7.8% | +2.9 points |
| Q4 2025 | 2.6% | +3.5 points |
| Q3 2025 | 5.7% | -13 points |
| Q2 2025 | 2.8% | -4.2 points |
| Q1 2025 | 4.9% | -7.6 points |
| Q4 2024 | -0.8% | -5.5 points |
CPHC has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
CPHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +$3.1M |
| Q2 2026 | $3.6M | +11% |
| Q1 2026 | $2.6M | +3.6% |
| Q4 2025 | -$611.3K | +$6.1M |
| Q3 2025 | -$395.3K | -$395.3K |
| Q2 2025 | $3.2M | +78% |
| Q1 2025 | $2.5M | +$3.1M |
| Q4 2024 | -$6.7M | -$5.7M |
CPHC has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over CPHC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
CPHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +54.4K shares |
| 1 year | +2.1% | +107K shares |
| 3 years | +5.2% | +258K shares |
| 5 years | +8.8% | +422K shares |
| Available history | +13% | +601K shares |
CPHC has 5M diluted shares, up 2.1% from a year ago.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
CPHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2026 | -2.0x | Net Cash |
| Q1 2026 | -1.8x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -2.0x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.2x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
CPHC has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
CPHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.0 | Neutral |
| Stochastic | 70.6 | Neutral |
CPHC's weekly RSI is 48 (neutral) and its Stochastic is 71 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over CPHC on valuation relative to its sector.
CPHC PE vs Consumer Cyclical Sector
| Metric | CPHC | Sector median | Relative |
|---|---|---|---|
| PE | 157x | 18x | 771% above |
| PE % | 92 | 47 | 45 pts above |
CPHC is trading at 157x earnings, a 771% premium to the Consumer Cyclical sector's median of 18x.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
CPHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.8 | 0.3% below |
| 20 week MA | $15.8 | 0.4% below |
| 50 week MA | $15.7 | 0.3% above |
| 100 week MA | $16.9 | 7% below |
| 200 week MA | $19.5 | 19% below |
CPHC has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
CPHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.4 | $12.4 | -0.5% |
| 2021 | $12.4 | $17.6 | +42% |
| 2022 | $17.6 | $28.8 | +64% |
| 2023 | $28.8 | $20.4 | -29% |
| 2024 | $20.4 | $21.9 | +7.2% |
| 2025 | $21.9 | $15.3 | -30% |
| 2026 YTD | $15.3 | $15.7 | +2.5% |
CPHC has the edge over BABA on returns for 2026, with the stronger performance.